LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
7.20
+0.55 (8.27%)
At close: May 20, 2026, 4:00 PM EDT
7.06
-0.14 (-1.94%)
After-hours: May 20, 2026, 4:21 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $225.75 million as of May 20, 2026. Its market cap has decreased by -71.84% in one year.
Market Cap
225.75M
Enterprise Value
-47.01M
1-Year Change
-71.84%
Ranking
Category
Stock Price
$7.20
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $225.75M, a decrease of -45.42%. That is a compound annual growth rate of -24.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 208.51M | -58.35% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 215.49M |
| MediWound | 214.44M |
| Sol-Gel Technologies | 212.48M |
| Foghorn Therapeutics | 211.37M |
| Voyager Therapeutics | 210.27M |
| Cybin | 209.15M |
| Unicycive Therapeutics | 206.39M |
| Entrada Therapeutics | 203.59M |